Indonesia Retailers - Limited surprises as expected
2Q24 review: ERAA upbeat and ACES downbeat were the only surprises Overall results were largely in line
Maintain Buy with higher TP of IDR1,430; roll forward base year to 2025F
3Q24 review: Within expectations
Overall, the results were in line with our expectations, as we believe that 2Q24 marked the lowest margin point for the year (read Lowest margin for the year). GPM improved q-q by +150bp, as the company completed its overseas inventory clearance in July while opex as a percentage of sales continued their quarterly recovery trend due to cost-cutting initiatives.
Further upside likely from potential SSSG resurgence
We anticipate continued improvement in GPM in 4Q24F, as we do not expect significant clearance activities and project 4Q to be MAPA's strongest quarter for the year. Although 3Q24 same-store sales growth (SSSG) remained at +4.5% y-y (+3.6% y-y for 9M24), we believe there's potential for SSSG to recover to management’s previous target of mid-to-high single-digit range for 2025F, driven by a lower base performance in 2024F and potentially better consumer buying power. This implies potential upside for the share price as we currently still forecast mid-single-digit SSSG for 2025-2026F, lower than the company’s medium-to-longer-term target of mid-to-high single-digit growth.
Maintain Buy with higher TP of IDR1,430 (+32% upside)
We raise our FY24F/25F/26F EPS estimates by +8%/+3%/+4%, following the stronger earnings recovery in 3Q24, which we believe marked the bottom of the margin cycle for the year in the second quarter. Consequently, we raise our target price to IDR1,430 (from IDR1,000), rolling forward our valuation base to 2025F with an unchanged target multiple of 20.6x 2025F P/E.
We believe that overall margins should continue to recover in 4Q24F as we expect more full-price sales after the inventory clearance ended in July 2024 and higher traffic towards the year-end holiday season. In the medium to longer term, the story of increasing adoption of sports and activewear, expansion into overseas markets, and potentially better consumer buying power next year should continue to position MAPA as the fastest-growing retailer in terms of revenue, with a 23% CAGR over 2023-2026F (compared to the retailers’ average of 14%). Currently, the stock is trading at 15.6x 2025F P/E.
Year-end 31 Dec | FY23 | FY24F | FY25F | FY26F | |||
Currency (IDR) | Actual | Old | New | Old | New | Old | New |
Revenue (bn) | 13,559 | 16,945 | 16,945 | 20,846 | 20,846 | 25,298 | 25,298 |
Reported net profit (bn) | 1,388 | 1,370 | 1,480 | 1,914 | 1,978 | 2,442 | 2,527 |
Normalised net profit (bn) | 1,388 | 1,370 | 1,480 | 1,914 | 1,978 | 2,442 | 2,527 |
FD normalised EPS | 48.71 | 48.05 | 51.91 | 67.14 | 69.39 | 85.66 | 88.65 |
FD norm. EPS growth (%) | 18.1 | -1.4 | 6.6 | 39.7 | 33.7 | 27.6 | 27.7 |
FD normalised P/E (x) | 22.3 | – | 20.9 | – | 15.6 | – | 12.2 |
EV/EBITDA (x) | 13.4 | – | 11.0 | – | 8.4 | – | 6.4 |
Price/book (x) | 5.4 | – | 4.3 | – | 3.4 | – | 2.6 |
Dividend yield (%) | 0.4 | – | – | – | – | – | – |
ROE (%) | 27.3 | 21.5 | 23.0 | 23.8 | 24.2 | 23.9 | 24.3 |
Net debt/equity (%) | net cash | net cash | net cash | net cash | net cash | net cash | net cash |
Income statement (IDRbn)
|
|||||||||||||||||||
Year-end 31 Dec
|
FY22
|
FY23
|
FY24F
|
FY25F
|
FY26F
|
||||||||||||||
Revenue
|
9,801
|
13,559
|
16,945
|
20,846
|
25,298
|
||||||||||||||
Cost of goods sold
|
-5,111
|
-6,961
|
-8,981
|
-11,048
|
-13,408
|
||||||||||||||
Gross profit
|
4,690
|
6,597
|
7,964
|
9,798
|
11,890
|
||||||||||||||
SG&A
|
-3,116
|
-4,564
|
-5,777
|
-6,991
|
-8,335
|
||||||||||||||
Employee share expense
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Operating profit
|
1,574
|
2,033
|
2,187
|
2,806
|
3,555
|
||||||||||||||
EBITDA
|
1,778
|
2,293
|
2,723
|
3,467
|
4,369
|
||||||||||||||
Depreciation
|
-204
|
-260
|
-537
|
-661
|
-814
|
||||||||||||||
Amortisation
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
EBIT
|
1,574
|
2,033
|
2,187
|
2,806
|
3,555
|
||||||||||||||
Net interest expense
|
-55
|
-114
|
-162
|
-111
|
-122
|
||||||||||||||
Associates & JCEs
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Other income
|
18
|
-52
|
-34
|
-34
|
-34
|
||||||||||||||
Earnings before tax
|
1,537
|
1,868
|
1,991
|
2,661
|
3,399
|
||||||||||||||
Income tax
|
-363
|
-484
|
-516
|
-690
|
-881
|
||||||||||||||
Net profit after tax
|
1,174
|
1,384
|
1,475
|
1,971
|
2,518
|
||||||||||||||
Minority interests
|
1
|
5
|
5
|
7
|
9
|
||||||||||||||
Other items
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Preferred dividends
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Normalised NPAT
|
1,175
|
1,388
|
1,480
|
1,978
|
2,527
|
||||||||||||||
Extraordinary items
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Reported NPAT
|
1,175
|
1,388
|
1,480
|
1,978
|
2,527
|
||||||||||||||
Dividends
|
0
|
-114
|
0
|
0
|
0
|
||||||||||||||
Transfer to reserves
|
1,175
|
1,274
|
1,480
|
1,978
|
2,527
|
||||||||||||||
Valuations and ratios
|
|||||||||||||||||||
Reported P/E (x)
|
26.3
|
22.3
|
20.9
|
15.6
|
12.2
|
||||||||||||||
Normalised P/E (x)
|
26.3
|
22.3
|
20.9
|
15.6
|
12.2
|
||||||||||||||
FD normalised P/E (x)
|
26.3
|
22.3
|
20.9
|
15.6
|
12.2
|
||||||||||||||
Dividend yield (%)
|
–
|
0.4
|
–
|
–
|
–
|
||||||||||||||
Price/cashflow (x)
|
18.8
|
24.1
|
15.8
|
16.3
|
12.4
|
||||||||||||||
Price/book (x)
|
6.9
|
5.4
|
4.3
|
3.4
|
2.6
|
||||||||||||||
EV/EBITDA (x)
|
16.7
|
13.4
|
11.0
|
8.4
|
6.4
|
||||||||||||||
EV/EBIT (x)
|
18.9
|
15.1
|
13.6
|
10.4
|
7.9
|
||||||||||||||
Gross margin (%)
|
47.9
|
48.7
|
47.0
|
47.0
|
47.0
|
||||||||||||||
EBITDA margin (%)
|
18.1
|
16.9
|
16.1
|
16.6
|
17.3
|
||||||||||||||
EBIT margin (%)
|
16.1
|
15.0
|
12.9
|
13.5
|
14.1
|
||||||||||||||
Net margin (%)
|
12.0
|
10.2
|
8.7
|
9.5
|
10.0
|
||||||||||||||
Effective tax rate (%)
|
23.6
|
25.9
|
25.9
|
25.9
|
25.9
|
||||||||||||||
Dividend payout (%)
|
0.0
|
8.2
|
0.0
|
0.0
|
0.0
|
||||||||||||||
ROE (%)
|
30.6
|
27.3
|
23.0
|
24.2
|
24.3
|
||||||||||||||
ROA (pretax %)
|
29.3
|
25.8
|
21.5
|
24.2
|
26.2
|
||||||||||||||
Growth (%)
|
|||||||||||||||||||
Revenue
|
62.2
|
38.3
|
25.0
|
23.0
|
21.4
|
||||||||||||||
EBITDA
|
251.1
|
29.0
|
18.8
|
27.3
|
26.0
|
||||||||||||||
Normalised EPS
|
368.8
|
18.1
|
6.6
|
33.7
|
27.7
|
||||||||||||||
Normalised FDEPS
|
368.8
|
18.1
|
6.6
|
33.7
|
27.7
|
||||||||||||||
Source: Company data, Verdhana estimates
|
|
Cashflow statement (IDRbn)
|
|||||||||||||||||||
Year-end 31 Dec
|
FY22
|
FY23
|
FY24F
|
FY25F
|
FY26F
|
||||||||||||||
EBITDA
|
1,778
|
2,293
|
2,723
|
3,467
|
4,369
|
||||||||||||||
Change in working capital
|
-127
|
-964
|
-62
|
-744
|
-850
|
||||||||||||||
Other operating cashflow
|
-6
|
-47
|
-707
|
-828
|
-1,028
|
||||||||||||||
Cashflow from operations
|
1,646
|
1,282
|
1,954
|
1,894
|
2,491
|
||||||||||||||
Capital expenditure
|
-341
|
-816
|
-956
|
-1,178
|
-1,246
|
||||||||||||||
Free cashflow
|
1,305
|
465
|
998
|
716
|
1,245
|
||||||||||||||
Reduction in investments
|
|
|
|
|
|
||||||||||||||
Net acquisitions
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Dec in other LT assets
|
|
|
|
|
|
||||||||||||||
Inc in other LT liabilities
|
|
|
|
|
|
||||||||||||||
Adjustments
|
-89
|
-362
|
-101
|
-117
|
-133
|
||||||||||||||
CF after investing acts
|
1,216
|
103
|
897
|
600
|
1,112
|
||||||||||||||
Cash dividends
|
0
|
-114
|
0
|
0
|
0
|
||||||||||||||
Equity issue
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Debt issue
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Convertible debt issue
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Others
|
-537
|
-232
|
12
|
12
|
12
|
||||||||||||||
CF from financial acts
|
-537
|
-346
|
12
|
12
|
12
|
||||||||||||||
Net cashflow
|
679
|
-242
|
909
|
612
|
1,124
|
||||||||||||||
Beginning cash
|
662
|
1,342
|
1,099
|
2,008
|
2,620
|
||||||||||||||
Ending cash
|
1,342
|
1,099
|
2,008
|
2,620
|
3,744
|
||||||||||||||
Ending net debt
|
-1,243
|
-368
|
-1,277
|
-1,889
|
-3,013
|
||||||||||||||
Balance sheet (IDRbn)
|
|||||||||||||||||||
As at 31 Dec
|
FY22
|
FY23
|
FY24F
|
FY25F
|
FY26F
|
||||||||||||||
Cash & equivalents
|
1,342
|
1,099
|
2,008
|
2,620
|
3,744
|
||||||||||||||
Marketable securities
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Accounts receivable
|
447
|
609
|
653
|
791
|
948
|
||||||||||||||
Inventories
|
2,733
|
4,315
|
4,546
|
5,593
|
6,787
|
||||||||||||||
Other current assets
|
313
|
419
|
523
|
644
|
781
|
||||||||||||||
Total current assets
|
4,834
|
6,442
|
7,731
|
9,647
|
12,260
|
||||||||||||||
LT investments
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Fixed assets
|
880
|
1,814
|
2,234
|
2,751
|
3,183
|
||||||||||||||
Goodwill
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Other intangible assets
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Other LT assets
|
1,712
|
2,548
|
2,649
|
2,766
|
2,899
|
||||||||||||||
Total assets
|
7,426
|
10,804
|
12,613
|
15,164
|
18,342
|
||||||||||||||
Short-term debt
|
99
|
731
|
731
|
731
|
731
|
||||||||||||||
Accounts payable
|
994
|
1,498
|
1,653
|
2,023
|
2,446
|
||||||||||||||
Other current liabilities
|
1,053
|
1,435
|
1,597
|
1,788
|
2,005
|
||||||||||||||
Total current liabilities
|
2,146
|
3,664
|
3,981
|
4,542
|
5,181
|
||||||||||||||
Long-term debt
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Convertible debt
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Other LT liabilities
|
807
|
1,263
|
1,280
|
1,299
|
1,320
|
||||||||||||||
Total liabilities
|
2,953
|
4,926
|
5,261
|
5,841
|
6,501
|
||||||||||||||
Minority interest
|
15
|
179
|
174
|
167
|
158
|
||||||||||||||
Preferred stock
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Common stock
|
1,111
|
1,111
|
1,111
|
1,111
|
1,111
|
||||||||||||||
Retained earnings
|
3,289
|
4,563
|
6,043
|
8,021
|
10,548
|
||||||||||||||
Proposed dividends
|
0
|
0
|
0
|
0
|
0
|
||||||||||||||
Other equity and reserves
|
58
|
24
|
24
|
24
|
24
|
||||||||||||||
Total shareholders' equity
|
4,458
|
5,699
|
7,178
|
9,156
|
11,683
|
||||||||||||||
Total equity & liabilities
|
7,426
|
10,804
|
12,613
|
15,164
|
18,342
|
||||||||||||||
Liquidity (x)
|
|||||||||||||||||||
Current ratio
|
2.25
|
1.76
|
1.94
|
2.12
|
2.37
|
||||||||||||||
Interest cover
|
28.7
|
17.9
|
13.5
|
25.2
|
29.2
|
||||||||||||||
Leverage
|
|||||||||||||||||||
Net debt/EBITDA (x)
|
net cash
|
net cash
|
net cash
|
net cash
|
net cash
|
||||||||||||||
Net debt/equity (%)
|
net cash
|
net cash
|
net cash
|
net cash
|
net cash
|
||||||||||||||
Per share
|
|||||||||||||||||||
Reported EPS (IDR)
|
41.24
|
48.71
|
51.91
|
69.39
|
88.65
|
||||||||||||||
Norm EPS (IDR)
|
41.24
|
48.71
|
51.91
|
69.39
|
88.65
|
||||||||||||||
FD norm EPS (IDR)
|
41.24
|
48.71
|
51.91
|
69.39
|
88.65
|
||||||||||||||
BVPS (IDR)
|
156.41
|
199.92
|
251.84
|
321.23
|
409.88
|
||||||||||||||
DPS (IDR)
|
0.00
|
4.00
|
0.00
|
0.00
|
0.00
|
||||||||||||||
Activity (days)
|
|||||||||||||||||||
Days receivable
|
14.2
|
14.2
|
13.6
|
12.6
|
12.5
|
||||||||||||||
Days inventory
|
179.0
|
184.8
|
180.6
|
167.5
|
168.5
|
||||||||||||||
Days payable
|
62.7
|
65.3
|
64.2
|
60.7
|
60.8
|
||||||||||||||
Cash cycle
|
130.4
|
133.7
|
130.0
|
119.4
|
120.2
|
||||||||||||||
Source: Company data, Verdhana estimates
|
|
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Remains | Buy |
Target price Increased from IDR 1,000 | IDR 1,430 |
Closing price 1 November 2024 | IDR 1,085 |
Implied upside | +31.8% |
Market Cap (USD mn) | 1,968.0 |
ADT (USD mn) | 1.6 |
Source: LSEG, Verdhana
M cap (USDmn) | 1,968.0 |
Free float (%) | 23.7 |
3-mth ADT (USDmn) | 1.6 |
(%) | 1M | 3M | 12M |
Absolute (IDR) | 16.7 | 26.2 | 46.6 |
Absolute (USD) | 12.8 | 30.3 | 48.6 |
Rel to Jakarta Stock Exchange Composite Index | 18.5 | 23.7 | 33.6 |
Jody Wijaya (jody.wijaya@verdhana.id),
Sandy Ham (sandy.ham@verdhana.id)
Samuel Christian (samuel.christian@verdhana.id)